Thanks ds for the link. One interesting point arising from the research paper;
Page 1 - Introduction: the point is made that with each of the collaboration agreements signed to date, AstraZeneca, Roche, Pfizer and J&J, that each can yield milestone payments in due course.
The inference appears to be that the collaborations are alive and active [rather than run their course and stalled]. What do we make of the language used in the research paper?
Thanks ds for the link. One interesting point arising from the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
-0.020(1.56%) |
Mkt cap ! $737.8M | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.29 | $1.25 | $4.616M | 3.649M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19940 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.27 | 1008 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |